Novo Nordisk

Novo Nordisk Eyes a Bigger Piece of the Diabetes Market
Novo Nordisk Eyes a Bigger Piece of the Diabetes Market
Medical Devices and Diagnostics Industry
Novo Nordisk
Biocorp
Bio Jag
diabetes
Flag link:
Novo Nordisk enters talks to buy device maker Biocorp
Novo Nordisk enters talks to buy device maker Biocorp
Medical Marketing and Media
Novo Nordisk
M&A
Medtech
Biocorp
Flag link:
Could Pfizer Have an Ozempic Killer on the Way?
Could Pfizer Have an Ozempic Killer on the Way?
Motley Fool
Pfizer
danuglipron
Novo Nordisk
Ozempic
weight loss
Flag link:
Novo Nordisk maintains its defense in case of high-priced insulin – competitor enters settlement
Novo Nordisk maintains its defense in case of high-priced insulin – competitor enters settlement
Medwatch
Novo Nordisk
insulin
diabetes
drug pricing
Flag link:
Novo Nordisk wins age discrimination case in US district court
Novo Nordisk wins age discrimination case in US district court
Medwatch
Novo Nordisk
age discrimination
legal
EEOC
Flag link:
Novo seeks a cardiovascular boost
Novo seeks a cardiovascular boost
EP Vantage
Novo Nordisk
Wegovy
Eli Lilly
Mounjaro
Flag link:
Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence
Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence
Biopharma Reporter
obesity
weight loss
Novo Nordisk
Eli Lilly
Pfizer
Amgen
Flag link:
This Could Be Novo Nordisk's Next Big Weight-Loss Product
This Could Be Novo Nordisk's Next Big Weight-Loss Product
Motley Fool
Novo Nordisk
weight loss
Wegovy
oral Wegovy
Flag link:
Pfizer's hemophilia drug hits in phase 3, giving it a chance to leapfrog Novo Nordisk
Pfizer's hemophilia drug hits in phase 3, giving it a chance to leapfrog Novo Nordisk
Fierce Biotech
Pfizer
Novo Nordisk
clinical trials
hemophilia
marstacimab
Flag link:
Noom to offer prescriptions for weight-loss drugs
Noom to offer prescriptions for weight-loss drugs
Yahoo Finance
Noom
weightloss
Novo Nordisk
Eli Lilly
Wegovy
Ozempic
Mounjaro
Flag link:
Novo marks a century in business with corporate campaign launch
Novo marks a century in business with corporate campaign launch
Medical Marketing and Media
Novo Nordisk
corporate branding
Flag link:
Novo makes a gene editing move
Novo makes a gene editing move
EP Vantage
Novo Nordisk
gene editing
Life Edit Therapeutics
Flag link:
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
Investors Business Daily
Pfizer
Novo Nordisk
weight loss
Ozempic
danuglipron
clinical trials
Flag link:
Novo Nordisk’s trial of oral semaglutide meets primary endpoint
Novo Nordisk’s trial of oral semaglutide meets primary endpoint
Clinical Trials Arena
Novo Nordisk
semaglutide
oral semaglutide
clinical trials
weight loss
Flag link:
Novo Nordisk pauses Wegovy marketing projects to dampen demand
Novo Nordisk pauses Wegovy marketing projects to dampen demand
Fierce Pharma
Novo Nordisk
Wegovy
weight loss
DTC advertising
Flag link:
What you need to know about pharma, PBM execs testifying on insulin prices
What you need to know about pharma, PBM execs testifying on insulin prices
Medical Marketing and Media
PBMs
insulin
diabetes
drug pricing
Sanofi
Novo Nordisk
Eli Lilly
Flag link:
A blockbuster year could be building
A blockbuster year could be building
EP Vantage
AbbVie
Amgen
AstraZeneca
Bristol Myers Squibb
Daiichi Sankyo
Eli Lilly
Gilead Sciences
Horizon Therapeutics
Merck
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
Flag link:
‘Robbing Peter to pay Paul’: Obesity experts debate risks of new weight loss drugs
‘Robbing Peter to pay Paul’: Obesity experts debate risks of new weight loss drugs
Stat
side effects
Ozempic
Wegovy
Mounjaro
Novo Nordisk
Eli Lilly
obesity
Flag link:
Amid high demand, Novo Nordisk temporarily throttles US supply of low-dose Wegovy
Amid high demand, Novo Nordisk temporarily throttles US supply of low-dose Wegovy
Fierce Pharma
Novo Nordisk
Wegovy
obesity
Flag link:
Novo Nordisk Q1 Earnings In Line, Sales Miss, View Up
Novo Nordisk Q1 Earnings In Line, Sales Miss, View Up
Yahoo/Zacks.com
Novo Nordisk
earnings
Flag link:

Pages